Esperion Therapeutics Inc (NAS:ESPR)
$ 2.12 0.12 (6%) Market Cap: 415.99 Mil Enterprise Value: 472.28 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 53/100

Esperion Therapeutics Inc Virtual R&D Day Hosted By LifeSci Transcript

Nov 09, 2022 / 03:00PM GMT
Release Date Price: $8.2 (+0.12%)
Operator

Good afternoon, and welcome to the Esperion event. (Operator Instructions) As a reminder, today's meeting is being recorded, and a replay will be made available on the Esperion website following the conclusion of the event. I would now like to turn the call over to your host, Sheldon Koenig, President and Chief Executive Officer of Esperion. Please go ahead, sir.

Sheldon L. Koenig
Esperion Therapeutics, Inc. - President, CEO & Director

Thank you so much, and good morning, everyone. It's a great pleasure for us today on behalf of the organization to have an R&D Day. We're really excited of the agenda that we have before us today. First, forward-looking statements and disclosure for your benefit, we'll not cover that, but let me run through the agenda.

We'll start with some opening remarks followed by following the science Esperion research and development. Our next item will be the importance of lowering LDL cholesterol and the royal bempedoic acid plays, which will be followed by the fire within inflammation is a common path in major chronic

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot